3 Min Read (Reuters) - Forward Health has raised $225 million from investors led by SoftBank Vision Fund 2 and Peter Thiel’s Founders Fund, in a late-stage funding round that values the healthcare startup at more than $1 billion. Forward uses biometric body scans, genetic testing and blood tests to assess what diseases a patient is likely to develop later in life and then uses that information to set customers up with health plans to help prevent those diseases. For instance, if tests show a person is at higher risk of developing heart disease, Forward Health will offer a custom-tailored program that the patient and doctor can use to help prevent specific heart diseases.